Objective.The object of present study was to investigate the effects of direct addition of Tribulus terrestris extract on human sperm parameters.Design.Semen specimens from 40 healthy men volunteers were divided into 4 groups: one group received no treatment (control group) while the others were incubated with 20, 40, and 50 µg/mL of T terrestris extract (experimental groups). Motility, viability, and DNA fragmentation were assessed in all groups.Results.The incubation of human semen with 40 and 50 μg/mL of T terrestris extract significantly enhanced total sperm motility, number of progressive motile spermatozoa, and curvilinear velocity over 60 to 120 minutes’ holding time (P < .05 or P < < .01). Furthermore, viability was significantly enhanced by using T terrestris extract (P < .01).Conclusions.In vitro addition of the T terrestris extract to human sperm could affect male fertility capacity.
Background and aimThere is some controversy about survival of coronary endarterectomy (CE) patients, so the current study aims to compare short and long term survival of patients undergoing off pump coronary artery bypass graft (OPCAB) with and without coronary endarterectomy.Patients and methodswe performed a retrospective analysis of data on patients undergoing OPCAB and CE between 2011 and 2012. Preoperative, perioperative and postoperative data collected from data bank. Follow-up information was obtained from telephone contact mean time 37.13 ± 23.82 months after surgery. Early and late outcomes were compared by univariate and Kaplan-Meier analysis.ResultOPCAB was performed in 474 patients, which 69 of them had a CE. The mean long term survival was similar between OPCAB (56.28 ± 0.61) and OPCAB + CE (55.54 ± 1.3) groups (p = 0.66). Multiple Cox regression shows that age, gender, BMI, EF and angina were significant predictors of mortality. Patients undergoing CE have a long term intensive care unit (ICU) stay (51.31 ± 5.59 vs 37.23 ± 0.88, P = 0.015) and blood transfusion was higher in CE group (650.62 ± 110 vs. 324.71 ± 22, P = 0.001).ConclusionThe current study demonstrates that results of CE are acceptable with respect to short and long -term survival. Patients undergoing CE required long term ICU stay and higher blood transfusion.
Cardiac blood cysts are rare benign neoplasms, usually involving the cardiac valves and are remnants of the Chiari network. They are usually detected in the first six months of life and rarely occur in children or adults. We report a 76-year-old male patient who was referred to the Imam Ali Hospital affiliated with Kermanshah University of Medical Sciences, Kermanshah, Iran, in 2018 with dyspnoea. Transthoracic echocardiography revealed a small patent foramen ovale (PFO) and a circumferential mobile cystic mass in the right atrium, with the impression of a tumour or thrombus. The patient underwent open-heart surgery with cardiopulmonary bypass to repair to PFO and remove the intra-atrial lesion. During surgical examination of the right atrial cavity, a blood cyst containing small stone-like structures on the coronary sinus valve of the right atrium was found. The post-operative course was uneventful and no recurrence of tumour was detected during six months of follow-up. To the best of our knowledge, this is the first reported case of a right atrial blood cyst with a few nodule-like stones in an adult with PFO in Iran and the second case in an adult with PFO worldwide.Keywords: Cyst; Coronary Sinus; Adult; Operative Surgical Procedure; Case Report; Iran.
Background:The Kermanshah Acute Coronary Syndrome (KACS) Registry, funded by Kermanshah University of Medical Sciences (KUMS). Currently, the patients diagnosed by ST-elevation myocardial infarction (STEMI), are recruited. The registry is aimed to be expanded to include all patients with the diagnosis of ACS including STEMI, in 2022 subject to the success of current project. Methods:In an ongoing cohort study, started July 2016, patients with a diagnosis of STEMI, being ≥18 years old, are recruited. The study proposal has been approved by KUMS' Ethics committee and European Observational Registry Program (EORP). The baseline data include patients' characteristics, presenting symptoms, past medical history, clinical findings, medical procedures and paramedical tests are collected via patient interview and using a check list and questionnaire developed by EORP. The patients will be followed up annually for a minimum of two years. Results:To date 2100 patients with STEMI have been recruited. Data on 220 variables for each participant has been collected. The first year follow up finished July 2018. We are analysing the results. An abstract entitled "Is any sex-specific difference in diabetes adverse effects on the outcomes of patients with myocardial infarction?" was presented at the 20th Asia Pacific Diabetes Conference in Australia (2018).The results gradually will be published. Conclusions:The data in this registry will provide detailed epidemiologic characteristics and a list of risk factors, clinical features, therapeutic approaches provided for patients and their complications. It creates the possibility of investigation of such patients for next two years after their STEMI. BackgroundMyocardial infarction (MI) refers to the presence of evidence of tissue necrosis associated with acute ischemic heart disease [1]. STsegment elevation myocardial infarction (STEMI) is the term used to describe a classic heart attack that is the most deadly sub-class of MI, and accounting for more than 35% of MI cases. The most common cause of myocardial infarction is coronary plaque rupture
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.